Haizhen Lu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center · ORCID：0000-0001-7564-794X

发表论文 75 篇 · 总被引 990 次 · h-index 15

代表论文

• Efficacy and safety of pembrolizumab with preoperative neoadjuvant chemotherapy in patients with resectable locally advanced head and neck squamous cell carcinomas (2023 · Frontiers in Immunology · 被引 56)
• PD-L1 and B7-H3 are Effective Prognostic Factors and Potential Therapeutic Targets for High-Risk Thyroid Cancer (2024 · Endocrine Pathology · 被引 11)
• PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study (2023 · Journal of Clinical Pathology · 被引 9)
• Pembrolizumab with Chemotherapy for Patients with Recurrent or Metastatic Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma: A Prospective Phase ll Study (2025 · Clinical Cancer Research · 被引 5)
• Clinicopathological features of incidentally detected metastatic thyroid papillary carcinoma in cervical lymph nodes of non-thyroid cancer patients: a retrospective analysis of 31cases (2023 · Diagnostic Pathology · 被引 3)
• Molecular mapping in head and neck adenoid cystic carcinoma by pathological grade using whole-exome sequencing and spatial transcriptome (2025 · Human Pathology · 被引 2)